Mechanisms underlying the therapeutic effects of banxiaxiexin decoction in treating vascular dementia based on network pharmacology and molecular docking
Authors:
Preprint
- 12 October 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background The Banxiaxiexin decoction constitutes a prevalent Traditional Chinese Medicine (TCM) formulation employed for the therapeutic intervention of vascular dementia. Despite its routine clinical application, the underlying molecular mechanisms that mediate its pharmacological efficacy remain elusive. To address this lacuna, the present study employed a multi-pronged analytical approach involving network pharmacology and molecular docking techniques. Methods Active phytochemical constituents and relevant pharmacological targets of Banxiaxiexin decoction were elucidated using data procured from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. Targets germane to vascular dementia were aggregated from a comprehensive range of databases, including GeneCards, Online Mendelian Inheritance in Man (OMIM), Drugbank, Pharmacogenomics Knowledge Base (PharmGKB), and Therapeutic Target Database (TTD). A Protein-Protein Interaction (PPI) network was constructed to isolate core targets. Subsequent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were executed using METASCAPE. Tissue and organ-specific distribution of these targets were subsequently assessed. Molecular docking protocols were employed to evaluate the interactions between the identified potential targets and active constituents. Molecular dynamics simulations were conducted to further scrutinize the optimal core protein–compound complexes identified through molecular docking. Results A total of 133 active compounds and 64 putative targets of Banxiaxiexin decoction were identified. Topological analyses of the PPI network revealed a subset of 20 core targets. GO and KEGG pathway enrichment analyses substantiated that Banxiaxiexin decoction modulates genes implicated in pathways associated with oncogenesis, lipid metabolism and atherosclerosis, as well as Alzheimer's disease signaling pathways. Both molecular docking and molecular dynamics simulations affirmed a robust binding affinity between the active compounds and the isolated targets. Conclusions The present study adeptly elucidates the active components, prospective targets, and putative pathways implicated in the therapeutic efficacy of Banxiaxiexin decoction for vascular dementia. The data presented herein offer a novel methodological framework for the future investigation of the molecular mechanisms by which Banxiaxiexin decoction exerts its therapeutic effects. Furthermore, the delineated active constituents may serve as a propitious reservoir for subsequent drug development endeavors targeting vascular dementia.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Naringenin improves learning and memory in an Alzheimer's disease rat model: Insights into the underlying mechanismsEuropean Journal of Pharmacology, 2015
- Association between Polymorphisms of the AKT1 Gene Promoter and Risk of the Alzheimer's Disease in a Chinese Han Population with Type 2 DiabetesCNS Neuroscience & Therapeutics, 2015
- Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's diseaseThe Journal of nutrition, health and aging, 2015
- Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of ratsNeurological Sciences, 2013
- Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in miceBehavioural Brain Research, 2010
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factorsThe Lancet Neurology, 2008
- Liver X receptor β (LXRβ): A link between β-sitosterol and amyotrophic lateral sclerosis–Parkinson's dementiaProceedings of the National Academy of Sciences, 2008
- Prevalence of Dementia in the United States: The Aging, Demographics, and Memory StudyNeuroepidemiology, 2007
- Quercetin, a natural flavonoid, attenuates vacuolar formation in the optic tract in rat chronic cerebral hypoperfusion modelBrain Research, 2003
- Mixed Dementia—the Most Common Cause of DementiaAnnals of the New York Academy of Sciences, 2002